PEDEVCO CORP (PED) Fundamental Analysis & Valuation

NYSEARCA:PED • US70532Y4026

Current stock price

15.87 USD
+0.77 (+5.1%)
At close:
15.25 USD
-0.62 (-3.91%)
After Hours:

This PED fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. PED Profitability Analysis

1.1 Basic Checks

  • PED had positive earnings in the past year.
  • In the past year PED had a positive cash flow from operations.
  • In multiple years PED reported negative net income over the last 5 years.
  • Each year in the past 5 years PED had a positive operating cash flow.
PED Yearly Net Income VS EBIT VS OCF VS FCFPED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • PED's Return On Assets of -2.76% is on the low side compared to the rest of the industry. PED is outperformed by 75.12% of its industry peers.
  • PED's Return On Equity of -5.00% is on the low side compared to the rest of the industry. PED is outperformed by 70.33% of its industry peers.
Industry RankSector Rank
ROA -2.76%
ROE -5%
ROIC N/A
ROA(3y)3.97%
ROA(5y)2.61%
ROE(3y)3.79%
ROE(5y)2.58%
ROIC(3y)N/A
ROIC(5y)N/A
PED Yearly ROA, ROE, ROICPED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

  • PED has a Gross Margin of 58.21%. This is in the better half of the industry: PED outperforms 67.46% of its industry peers.
  • PED's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y5.32%
PED Yearly Profit, Operating, Gross MarginsPED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K -1K

1

2. PED Health Analysis

2.1 Basic Checks

  • PED does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PED has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PED has been increased compared to 5 years ago.
  • The debt/assets ratio for PED is higher compared to a year ago.
PED Yearly Shares OutstandingPED Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PED Yearly Total Debt VS Total AssetsPED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • PED has an Altman-Z score of 0.26. This is a bad value and indicates that PED is not financially healthy and even has some risk of bankruptcy.
  • PED has a Altman-Z score of 0.26. This is in the lower half of the industry: PED underperforms 66.03% of its industry peers.
  • PED has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • PED has a Debt to Equity ratio (0.42) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACCN/A
WACC7.59%
PED Yearly LT Debt VS Equity VS FCFPED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 0.59 indicates that PED may have some problems paying its short term obligations.
  • With a Current ratio value of 0.59, PED is not doing good in the industry: 82.30% of the companies in the same industry are doing better.
  • PED has a Quick Ratio of 0.59. This is a bad value and indicates that PED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PED has a worse Quick ratio (0.58) than 73.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.58
PED Yearly Current Assets VS Current LiabilitesPED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

7

3. PED Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 185.71% over the past year.
  • PED shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.67%.
  • The Revenue has been growing by 24.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-170.36%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%118.25%

3.2 Future

  • PED is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -34.36% yearly.
  • Based on estimates for the next years, PED will show a very strong growth in Revenue. The Revenue will grow by 45.26% on average per year.
EPS Next Y-120.2%
EPS Next 2Y-47.06%
EPS Next 3Y-34.36%
EPS Next 5YN/A
Revenue Next Year-2.61%
Revenue Next 2Y80.37%
Revenue Next 3Y45.26%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PED Yearly Revenue VS EstimatesPED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
PED Yearly EPS VS EstimatesPED Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

4

4. PED Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 3.97, the valuation of PED can be described as very cheap.
  • PED's Price/Earnings ratio is rather cheap when compared to the industry. PED is cheaper than 97.61% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.53, PED is valued rather cheaply.
  • PED is valuated correctly with a Price/Forward Earnings ratio of 14.16.
  • Based on the Price/Forward Earnings ratio, PED is valued a bit cheaper than the industry average as 64.59% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 37.95. PED is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 3.97
Fwd PE 14.16
PED Price Earnings VS Forward Price EarningsPED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PED is valued a bit more expensive than the industry average as 67.46% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.25
PED Per share dataPED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as PED's earnings are expected to decrease with -34.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.06%
EPS Next 3Y-34.36%

0

5. PED Dividend Analysis

5.1 Amount

  • PED does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PED Fundamentals: All Metrics, Ratios and Statistics

PEDEVCO CORP

NYSEARCA:PED (4/16/2026, 8:04:00 PM)

After market: 15.25 -0.62 (-3.91%)

15.87

+0.77 (+5.1%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners0.84%
Inst Owner Change7.5%
Ins Owners4.13%
Ins Owner Change1.6%
Market Cap211.07M
Revenue(TTM)45.75M
Net Income(TTM)-10.36M
Analysts80
Price Target18.36 (15.69%)
Short Float %N/A
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)22.15%
Min Revenue beat(2)-11.17%
Max Revenue beat(2)55.47%
Revenue beat(4)1
Avg Revenue beat(4)2.62%
Min Revenue beat(4)-28.89%
Max Revenue beat(4)55.47%
Revenue beat(8)5
Avg Revenue beat(8)8.2%
Revenue beat(12)7
Avg Revenue beat(12)5.99%
Revenue beat(16)9
Avg Revenue beat(16)4.68%
PT rev (1m)2017.65%
PT rev (3m)2017.65%
EPS NQ rev (1m)2450%
EPS NQ rev (3m)2450%
EPS NY rev (1m)1950%
EPS NY rev (3m)1950%
Revenue NQ rev (1m)-1.08%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)-17.7%
Revenue NY rev (3m)-17.7%
Valuation
Industry RankSector Rank
PE 3.97
Fwd PE 14.16
P/S 4.61
P/FCF N/A
P/OCF 19.62
P/B 1.02
P/tB 1.02
EV/EBITDA 28.25
EPS(TTM)4
EY25.2%
EPS(NY)1.12
Fwd EY7.06%
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)0.81
OCFY5.1%
SpS3.44
BVpS15.59
TBVpS15.59
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.4595 (136.04%)
Profitability
Industry RankSector Rank
ROA -2.76%
ROE -5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.21%
FCFM N/A
ROA(3y)3.97%
ROA(5y)2.61%
ROE(3y)3.79%
ROE(5y)2.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y5.32%
F-Score2
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 8.84
Cap/Depr 113.75%
Cap/Sales 44.78%
Interest Coverage N/A
Cash Conversion 109.3%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.58
Altman-Z 0.26
F-Score2
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)203.87%
Cap/Depr(5y)156.84%
Cap/Sales(3y)76.44%
Cap/Sales(5y)59.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-170.36%
EPS Next Y-120.2%
EPS Next 2Y-47.06%
EPS Next 3Y-34.36%
EPS Next 5YN/A
Revenue 1Y (TTM)15.67%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%118.25%
Revenue Next Year-2.61%
Revenue Next 2Y80.37%
Revenue Next 3Y45.26%
Revenue Next 5YN/A
EBIT growth 1Y-270.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1690.7%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.73%
OCF growth 3Y-12.36%
OCF growth 5Y303.97%

PEDEVCO CORP / PED Fundamental Analysis FAQ

What is the fundamental rating for PED stock?

ChartMill assigns a fundamental rating of 3 / 10 to PED.


What is the valuation status for PED stock?

ChartMill assigns a valuation rating of 4 / 10 to PEDEVCO CORP (PED). This can be considered as Fairly Valued.


How profitable is PEDEVCO CORP (PED) stock?

PEDEVCO CORP (PED) has a profitability rating of 3 / 10.


What is the valuation of PEDEVCO CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PEDEVCO CORP (PED) is 3.97 and the Price/Book (PB) ratio is 1.02.


Can you provide the expected EPS growth for PED stock?

The Earnings per Share (EPS) of PEDEVCO CORP (PED) is expected to decline by -120.2% in the next year.